In the specialized field of biochemical research and peptide synthesis, the abaloparatide peptide API stands out as a Abaloparatideis a parathyroid hormone-related protein (PTHrP) analogused for the treatment of osteoporosis in patients with a high risk of fracture. significant focus for developers and laboratory professionals. As a synthetic 34 amino acid peptide, this compound represents a sophisticated achievement in molecular engineering, specifically designed as an analog of human parathyroid hormone-related protein (PTHrP).
The Molecular Profile of Abaloparatide
Abaloparatide is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP), often categorized as a human parathyroid hormone-related peptide [PTHrP(1-34)] analog. Its structural design is precise, consisting of a 34 amino acid chain that mimics natural biological signaling pathways. For researchers and companies involved in the production of high-quality APIs for peptides—such as Polypeptide Laboratories (PPL)—maintaining the integrity of this sequence is paramount.
The compound is recognized for its stability and precision-controlled purification, which are essential when evaluating its potential in advanced formulation development. Because it is a 34 amino acid peptide, it is typically produced through advanced solid-phase peptide synthesis (SPPS) techniques, which ensure the high purity required for analytical study.
Technical Specifications and API Manufact Application: Investigated for use/treatment in postmenopausal osteoporosis to reduce vertebral and/or non-vertebral fractures. Pharmaceutical Application: Read more uring
When discussing the abaloparatide API, it is vital to distinguish between the raw peptide and the final drug product. The API (Active Pharmaceutical Ingredient) i Abaloparatide API | CAS 247062-33-5 Manufacturer & s the core active component. Manufacturers often focus on the CAS 247062-33-5, which identifies this specific synthetic peptide.
For those looking into the technical aspects:
* Structure: A 34 amino acid synthetic analog of human PTHrP.
* Solubility: The substance is known to be freely soluble in water, which aids in the creation of stable aqueous formulations.
* Manufacturing: The process requires rigorous quality control, including high-performance liquid chromatography (HPLC) to verify purity levels.
The market for this peptide continues to grow, with the abaloparatide API representing a critical advancement in osteoporosis treatment research. As stakeholders look at the revenue forecast, the focus remains on the scalability of synthesis and the development of stable, long-lasting delivery TYMLOS injection for subcutaneous administrationcontains abaloparatide, a synthetic 34 amino acid peptide. Abaloparatide is an analog of human parathyroid Read more systems.
Practical Considerations for Researchers
For those exploring this peptide in a laboratory or investigatio Abaloparatide acetateis a peptide hormone that belongs to the calcitonin family. It is an analog of human calcitonin, which is a hormone that regulates bone Read more nal setting, the focus is often on its mechanism of action and structural efficacy. Abaloparatide is categorized as a parathyroid hormone-related protein (PTHrP) analog, which is a novel synthetic peptide analog of PTH-related protein.
When evaluating the TYMLOS injection for subcutaneous administration, prof Abaloparatide - StatPearls - NCBI Bookshelf - NIH essionals often note that this product is recognized for its precision-controlled purification. It is a parathyroid hormone-related protein (PTHrP) analog drug that serves as a cornerstone in modern bone-related research. While some literature notes it as a peptide hormone, it is distinct from others in the calcitonin family, as it is a parathyroid hormone-related protein (PTHrP) analogue medication.
Integration in Modern Science
The development of abaloparatide Peptide Drug-Abaloparatide has been a multi-year journey, evolving from its early identification as a candidate for bone-density research to being a widely recognized synthetic peptide used in osteoporosis treatment. It is used to manage and treat osteoporosis through its unique ability to modulate bone remodeling pathways.
For many, the appeal of this API lies in its potential to offer a targeted approach. As a peptide, it provides a level of specificity that smaller molecules often cannot achieve. Whether investigating its role in bone-growing or analyzing its stability for future clinical applications, the abaloparatide API remains a subject of intense scientific interest.
In summary, the synthesis and formulation of abaloparatide represent the inte Abaloparatide rsection of complex peptide chemistry and practical, high-stakes application. By focusing on the precision of the 34-amino acid structure and maintaining high standards for the abaloparatide API, researchers continue to unlock the potential of this molecule in various scientific contexts.